Clinical Excellence – From Molecule To Milestone
Ypsomed accelerates clinical progress by reducing barriers across clinical development, enabling earlier study readiness, greater visibility and more informed decisions.
Accelerate clinical progress
Start clinical studies earlier with trial-ready platform devices and streamlined clinical supply pathways.
Enable operational excellence
Reduce unnecessary effort across the clinical trial journey and integrate seamlessly into existing workflows.
Reduce clinical uncertainty
Strengthen clinical predictability through proven platform devices and real-time trial insights.
Where our solutions for clinical trials fit
Clinic-ready autoinjectors
Clear to Clinic
- Validated platform data
- Reduced development uncertainty
- Submission-oriented documentation
Enhanced injection data
CliniPilot
- Collect objective injection adherence data
- Integration with major EDC systems to improve trial efficiency
- Support for decentralized and hybrid trials
Ypsomed perspective: Many clinical timelines are set before the delivery device is considered
By the time a delivery device is selected, many of the decisions that shape clinical timelines have already been made. Study design, formulation, presentation and regulatory strategy influence whether a device becomes an enabler or a bottleneck.
At Ypsomed, we believe the greatest opportunity to accelerate clinical development lies in addressing these decisions early through proven platform devices and connected technologies for adherence tracking in clinical trials.